Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy.

Br J Cancer · 2010 · PMC2883154 · PMID 20461087

Europe PMC DOI

hedged sentence

0.8700

closest p · 17.4× alpha

0.8700

boldest claim

The sentences

did not reach statistical significanceP =0.87not close (p > 0.1)

Similar trend was also observed for disease-specific survival, although it did not reach statistical significance (mean survival 68.6 months (TRG 1–3) compared with 53.9 months (TRG 4 and 5); P =0.87; Figure 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.